NFKB1 and ovarian cancer: On the other hand, a gradual reduction of AMPK activation due to the subsequent high ATP production led to the activation of mTOR and TAK1/NF-κB signaling, which in turn, enhanced ovarian cancer metastasis and aggressiveness.